Strengthening Quality Assurance, Audits and Traceability
First written in FY2016. 8 of 13 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2026: 5 of 46 companies on the "Worse" side.
30 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「During the period, the Audit Department conducted operational audits of our operational organizations and Group companies, covering a total of 30 locations.」
Operational audits were conducted at 30 operational organizations and Group companies, and the record of audit operations covering quality, safety and internal controls was updated. - FY2024-Q2RestatedAnnual report
「No new business or other risks arose during the cumulative second-quarter period. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The disclosure states that there were no new developments or significant changes regarding risks related to quality assurance, audits and traceability. - FY2023AdvancedAnnual report
「During the period, the Audit Department conducted operational audits of our operational organizations and Group companies, covering a total of 30 locations.」
As a record of internal audit operations, including quality and safety, the disclosure reported that the audit scope had been expanded to a total of 30 locations. - FY2022-Q2RestatedAnnual report
「No new business or other risks arose during the cumulative second-quarter period. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The disclosure states that there were no significant changes regarding risks related to quality assurance, audits and traceability. - FY2021-Q3RestatedAnnual report
「No new business or other risks arose during the cumulative third-quarter period. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The disclosure states that there were no significant changes regarding risks related to quality assurance, audits and traceability. - FY2021-Q2RestatedAnnual report
「No new business or other risks arose during the cumulative second-quarter period. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The disclosure states that there were no significant changes regarding risks related to quality assurance, audits and traceability. - FY2019AdvancedAnnual report
「・Thorough implementation of quality assurance activities based on the Ajinomoto Group Quality Assurance System, ASQUA, and human resource development」
Activities based on the ASQUA quality assurance system and human resource development were identified as key initiatives supporting product safety and security. - FY2018AdvancedAnnual report
「In the pharmaceutical active ingredient manufacturing division, systems that store records and analytical data related to manufactured products in a state protected from unauthorized alteration are required as a global standard. This is known as data integrity, and we are further strengthening controls to comply with it, while implementing similar enhancements progressively in the food manufacturing division.」
The scope of quality assurance was expanded from data integrity for pharmaceutical active ingredients to the food manufacturing division, with controls being strengthened progressively. - FY2018-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The disclosure states that there were no significant changes regarding risks related to quality assurance, audits and traceability. - FY2017-Q3RestatedAnnual report
「There were no newly arising business or other risks during the cumulative consolidated period for the third quarter. Nor were there any material changes to the business or other risks described in the securities report for the previous fiscal year.」
The disclosure states that there were no significant changes regarding risks related to quality assurance, audits and traceability. - FY2017-Q2RestatedAnnual report
「There were no newly arising business or other risks during the cumulative consolidated period for the second quarter. Nor were there any material changes to the business or other risks described in the securities report for the previous fiscal year.」
The disclosure states that there were no significant changes regarding risks related to quality assurance, audits and traceability. - FY2017-Q1RestatedAnnual report
「There were no newly arising business or other risks during the cumulative consolidated period for the first quarter. Nor were there any material changes to the business or other risks described in the securities report for the previous fiscal year.」
The disclosure explicitly states that there were no significant changes in overall risks related to quality assurance, audits and traceability. - FY2016First statedAnnual report
「Our Group is taking comprehensive measures to ensure the safety and security that underpin all its businesses, including further strengthening its proprietary, rigorous quality assurance system, conducting quality audits across the Group, and focusing on building a traceability system that tracks information at each stage of a product's production, processing and distribution.」
Quality standards and guidelines, manufacturing facilities, and the organizational culture, including labor and human rights, are also subject to strengthening measures.